Cigarettes with ultralow nicotine levels are now being called the game-changer in the fight against smoking. If you are having trouble in quitting smoking, then, it is for you, that soon the Biden White House is expected to formally propose a plan that will order cigarette nicotine levels to be reduced, reports The Washington Post. For now though, it has been a failure, as these cigarettes, also known as VLN cigarettes that stands for very low nicotine are only available in 5,100 stores in 26 states. This is a very small fraction of the overall market for cigarettes. The company that makes it, 22nd Century, is struggling not because of the low supply, but also from the advocates who have long believed slashing nicotine levels altogether.
Nicotine is a chemical that is produced naturally from tobacco that makes the cigarette and also keeps people hooked. While it is believed that it makes people alert, and get the "hit" to keep them going, it exposes the users to harmful substances, carcinogens, and increases the risk of heart disease, lung cancer, and other illness.
Ultralow-nicotine cigarettes, like the VLN brand, contain about 95% less nicotine than the regular cigarettes. The idea is quite simple: without the addictive grip of nicotine, smokers will find it easier to quit. Research too has shown some promise. For instance, the studies funded by the National Institute on Drug Abuse revealed that very low nicotine cigarettes reduced addiction potential significantly without having users to increase their smoking frequency. However, the problem is, why would anyone choose for a low-nicotine that does not make them feel the same way, when the high-nicotine cigarette is right next to it, making them feel the same way, with the same alertness, sold at the same price.
“It’s very hard to imagine someone actively choosing to continue to use a low-nicotine product for the same price when a high-nicotine product is right next to it,” said Eric Donny, a Wake Forest University School of Medicine nicotine researcher.
No wonder, the experiment with low nicotine product by Philip Morris' Next cigarettes in the 1980s and Vector Tobacco's Quest brand in the early 2000s, flopped.
The Food and Drug Administration (FDA) has supported the development of such products, even allowing VLN cigarettes to be marketed as lower-risk options. However, these products remain a niche market, available in only a fraction of U.S. stores.
Recently, the Biden administration has considered a bold step—mandating a dramatic reduction in nicotine levels for all cigarettes sold in the United States. Supporters believe this move could save millions of lives, while critics, including tobacco companies, warn of potential unintended consequences.
Resistance from Big Tobacco Companies: They could argue that slashing nicotine levels could backfire. Their claim is, smokers will turn to black markets or smoke more to satisfy their cravings, which may lead to greater exposure to harmful substances.
Consumer Reluctance: History is proof to the instances of smokers being hesitant to embrace the low-nicotine products.
Political Hurdle: It may face political roadblocks, as under the Trump administration, plans to cut nicotine were shelved.
Advocates believe that ultralow-nicotine cigarettes could be a game-changer, comparing them to decaf coffee or non-alcoholic beer—products that reduce harm while offering a similar experience.
Some experts warn that a black market for traditional cigarettes could undermine these efforts. They also stress the need for safer alternatives, such as vaping products, to support smokers transitioning away from traditional cigarettes.
Credit: iStock
Life-threatening bleeding episodes among US infants have risen sharply as more parents refuse the routine vitamin K shot given at birth, two new studies have found.
Published in JAMA and JAMA Pediatrics, the studies found that the proportion of newborns who missed the vitamin K shot more than doubled between 2017 and 2025, reaching 6.8%. These infants were also more likely to experience bleeding, including bleeding in the brain.
Although the studies do not establish causation, the parallel rise in refusals and bleeding episodes is significant, said Dr Steven Woolf, an epidemiologist at Virginia Commonwealth University and lead author of the JAMA Pediatrics study, as reported by NBC News.
"Now we're stepping away from that, and we're seeing the consequences," Woolf said.
Vitamin K shots have been standard newborn care since 1961 and help prevent vitamin K deficiency bleeding (VKDB), a rare but potentially life-threatening condition.
Woolf and colleagues analysed medical records of more than 11 million infants aged six months and younger between 2017 and 2025.
During this period, the proportion of newborns receiving a vitamin K shot fell from 97.7% to 95%, while vitamin K deficiency bleeding nearly quadrupled.
The researchers identified 5,217 bleeding events during the study period. The rate in 2025 was approximately double that in 2024, Woolf said.
The researchers noted that the increase coincided with declining public trust following the COVID-19 pandemic, growing vaccine hesitancy and parental scepticism about routine newborn interventions.
A separate JAMA study by Dr Kristan Scott and colleagues analysed medical records of more than 5.2 million US infants born between 2017 and 2025.
The proportion of newborns who missed the vitamin K shot rose from 3.1% in 2017 to 6.8% in 2025. It had reached 5.1% by the end of 2024.
The study also found that infants who did not receive the shot had:
The authors estimated that one additional bleeding event would occur for every 114 newborns who missed the vitamin K shot.
Separately, an analysis of more than one million births by health data company Truveta for Reuters found that vitamin K refusals increased by more than 57% between January and June 2026.
Vitamin K is a fat-soluble nutrient essential for blood clotting and bone health. Newborns naturally have low levels, leaving them vulnerable to VKDB.
The American Academy of Pediatrics (AAP) has recommended a vitamin K injection for all newborns since 1961.
Without adequate vitamin K, babies can develop spontaneous bleeding, including severe internal bleeding and bleeding in the brain. These episodes can cause permanent brain damage or death.
Importantly, the vitamin K shot is not a vaccine. It is a one-time injection given shortly after birth to protect babies against VKDB.
Breast milk contains relatively little vitamin K. Exclusively breastfed babies who miss the birth injection therefore remain vulnerable to deficiency bleeding.
The researchers also found increased use of oral vitamin K. However, oral doses are less effective than intramuscular injections, particularly in preventing late-onset VKDB, which can occur weeks or months after birth.
Vitamin K refusals have risen since the COVID-19 pandemic amid growing parental concerns about vaccines and routine newborn interventions.
Health experts have also raised concerns about declining trust in health authorities and mixed messages surrounding preventive care.
Refusals have accelerated under US Health Secretary Robert F Kennedy Jr, who has questioned vaccine safety and overseen changes to federal childhood vaccination recommendations.
A US Department of Health and Human Services spokesperson said the Centers for Disease Control and Prevention (CDC) continues to recommend vitamin K shots for newborns. However, the department did not say whether the agency would begin tracking refusals or associated bleeding episodes.
Credit: iStock
Measles, a highly contagious but vaccine-preventable disease, has claimed another young life. Wisconsin has reported its first measles-related death since 1990, taking the reported US death toll to eight in 2026.
The US, which eliminated sustained domestic measles transmission in 2000, is witnessing a major resurgence. The Centers for Disease Control and Prevention (CDC) reported 4,852 confirmed measles cases as of October 29.
According to state health department reports, the country has recorded eight measles-related deaths this year: six in Pennsylvania, one in New York and one in Wisconsin. At least four involved children or infants.
However, the CDC has not yet updated its website and has confirmed only four measles-associated deaths so far this year.
Childhood vaccination rates have declined in recent years, falling below the 95% coverage generally needed to prevent outbreaks.
Disruptions to routine childhood immunisation during the COVID-19 pandemic, declining vaccination coverage and growing vaccine hesitancy have contributed to the resurgence. Vaccine scepticism has also been amplified by anti-vaccine messaging from the Donald Trump-led administration, including Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.
Also read: Pennsylvania Reports Sixth Measles Death As Outbreak Crosses 1,400 Cases Across 45 Counties
The Wisconsin Department of Health Services (DHS) reported the death of an infant due to measles, marking the state's first such death since 1990.
The coroner listed measles as the immediate cause of death, according to the official statement. DHS said it would not release additional information to protect the privacy of the child and family.
"It is with a heavy heart we are reporting the first death of an infant connected with a measles outbreak in Wisconsin in many years. My heart is broken for the family," said DHS Secretary Kirsten Johnson.
"Any death of a child is a tragedy and even more so when it is related to a vaccine-preventable disease. Measles can cause serious illness and death, and all Wisconsinites need to evaluate their risk and take steps to protect themselves and their family."
As of November 3, Wisconsin had reported 431 measles cases across 13 counties in 2026, the highest number recorded in the state in more than 35 years. Nine people have required hospitalisation due to severe symptoms.
Reported case counts may not reflect the full extent of transmission. Not everyone who develops symptoms seeks medical care or undergoes testing, meaning some infections may go unreported.
Declining childhood vaccination coverage is a major concern. US vaccination rates have fallen below the 95% coverage generally needed to prevent measles outbreaks.
Children younger than five years, pregnant people and those with weakened immune systems are at increased risk of severe complications.
Two doses of the measles, mumps and rubella (MMR) vaccine are approximately 97% effective against measles. Children as young as six months may receive an early dose in certain circumstances, including travel to areas experiencing outbreaks. This early dose does not replace the two routine doses recommended later in childhood.
Measles spreads through the air when an infected person coughs or sneezes. The virus can remain infectious in the air or on surfaces for up to two hours.
Initial symptoms include:
A rash usually develops several days later, beginning on the face and spreading down the body.
Although many people recover, measles can cause serious and potentially life-threatening complications, including pneumonia and encephalitis, or inflammation of the brain. The infection can also weaken the immune system, increasing vulnerability to other infections.
Credit: iStock
The sudden collapse and death of a nine-year-old girl inside her Delhi classroom following a cardiac arrest has raised concerns about sudden cardiac emergencies in children. The Class 3 student reportedly collapsed shortly after returning to the classroom from a games period.
CCTV footage showed her entering the classroom, holding her waist and falling to the floor. A teacher rushed to help her, while school staff took her to a nearby hospital. She was subsequently taken to another hospital in Nirman Vihar, where doctors declared her dead.
Speaking to HealthandMe, Dr Neeraj Awasthy, Senior Director, Pediatric Cardiology, Fortis Hospital, Okhla, said the heart condition in children are extremely rare and differ from those in adults.
"In adults, a heart attack is usually caused by a blockage in the arteries supplying the heart. In children, sudden cardiac arrest is more often associated with an underlying heart condition, such as a structural abnormality, an inherited problem affecting the heart rhythm or inflammation of the heart muscle," he said.
According to Dr Awasthy, sudden cardiac arrest in children is commonly associated with structural heart abnormalities, inherited rhythm disorders and inflammation of the heart muscle.
In a post on X, Dr Sudhir Kumar, Neurologist at Apollo Hospitals, Hyderabad, identified other conditions that can trigger cardiac arrest in apparently healthy children:
Some children may have no symptoms until a life-threatening cardiac arrhythmia occurs, he noted.
Nearly one in five sudden cardiac deaths in young people may have a definite genetic explanation, according to scientist Vinod Scaria.
In a post on X, he identified three groups of inherited conditions linked to this risk:
An analysis of Indian genomes found variants associated with channelopathies in approximately 1% of individuals, cardiomyopathies in more than 1.5% and familial hypercholesterolaemia in about one in 150 individuals, Scaria said.
A molecular autopsy can identify genetic causes that a conventional autopsy may miss. Since many of these conditions are inherited in an autosomal dominant manner, up to half of first-degree relatives could carry the same genetic variant.
People with a family history of unexplained sudden death or inherited heart disease should seek genetic counselling.
Read More: Energy Drinks Linked To More Heart Problems In Young Adults: Study Flags Cardiac Risks
Dr Awasthy and Dr Kumar highlighted the following warning signs:
Dr Kumar said immediate cardiopulmonary resuscitation (CPR) and access to an automated external defibrillator (AED) can save a child's life if they collapse and are unresponsive or not breathing normally. He also outlined the steps teachers and bystanders should take:
For a school-age child, he advised:
Dr Kumar recommended that schools:
© $2026 Times Horizon Private Limited